Partner Content Partner Content FREE TO ATTEND | Inhalation & Respiratory Drug Delivery Even... 08 - 09 July 2020 | BST (UTC+1) | FREE TO ATTEND
Partner Content Partner Content FREE TO ATTEND | Formulation & Drug Delivery Event: Virtual FREE TO ATTEND
News Verona says FDA backs plan to take COPD drug into phase 3 More than two years after first saying it would take its lead drug into a pivotal trial, Verona Pharma looks like it may finally follow through on that promise.
News Chiesi starts rare diseases division, ahead of potential Fab... Italian pharma Chiesi has begun a new rare diseases division as it builds towards a potential commercial launch for its Fabry Disease therapy.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.